BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loizzo D, Pandolfo SD, Rogers D, Cerrato C, di Meo NA, Autorino R, Mirone V, Ferro M, Porta C, Stella A, Bizzoca C, Vincenti L, Spilotros M, Rutigliano M, Battaglia M, Ditonno P, Lucarelli G. Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review. Int J Mol Sci 2022;23:3826. [PMID: 35409187 DOI: 10.3390/ijms23073826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pandolfo SD, Del Giudice F, Chung BI, Manfredi C, De Sio M, Damiano R, Cherullo EE, De Nunzio C, Cacciamani GE, Cindolo L, Porpiglia F, Mirone V, Imbimbo C, Autorino R, Crocerossa F. Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases. Prostate Cancer Prostatic Dis 2022. [DOI: 10.1038/s41391-022-00616-4] [Reference Citation Analysis]
2 Kim J, Hwang KW, Lee HJ, Kim HS. Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer. JPM 2022;12:1818. [DOI: 10.3390/jpm12111818] [Reference Citation Analysis]
3 Di Minno A, Aveta A, Gelzo M, Tripodi L, Pandolfo SD, Crocetto F, Imbimbo C, Castaldo G. 8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP). JCM 2022;11:6102. [DOI: 10.3390/jcm11206102] [Reference Citation Analysis]
4 Harris AE, Metzler VM, Lothion-roy J, Varun D, Woodcock CL, Haigh DB, Endeley C, Haque M, Toss MS, Alsaleem M, Persson JL, Gudas LJ, Rakha E, Robinson BD, Khani F, Martin LM, Moyer JE, Brownlie J, Madhusudan S, Allegrucci C, James VH, Rutland CS, Fray RG, Ntekim A, de Brot S, Mongan NP, Jeyapalan JN. Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. Front Endocrinol 2022;13:1006101. [DOI: 10.3389/fendo.2022.1006101] [Reference Citation Analysis]
5 Mosillo C, Calandrella ML, Caserta C, Macrini S, Guida A, Sirgiovanni G, Bracarda S. Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data? Cancers 2022;14:4189. [DOI: 10.3390/cancers14174189] [Reference Citation Analysis]
6 Cahuzac M, Péant B, Mes-masson A, Saad F. Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance. Cancers 2022;14:3877. [DOI: 10.3390/cancers14163877] [Reference Citation Analysis]